August 31, 2026

Trump to Announce New Drug Pricing Deals with Major Pharmaceutical Companies

Nearly a dozen drugmakers are expected to sign agreements with President Trump to reduce outpatient drug prices for state Medicaid programs.
The new deals will allow companies to avoid mandatory discounts in Medicare in exchange for providing lower prices to Medicaid.
This initiative builds on previous agreements under the 'most favored nation' policy, which links U.S. drug prices to those abroad.

Read the news this way every day.

Concur organizes political reporting into clear stories and shows the sources behind each one.

Free. No ads.